Search
for
Sort by
Research 31–60 of 58
- Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Metabolic syndrome and dermatological diseases: association and treatment
- The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015
- 11-Oxyandrogens in Adolescents With Polycystic Ovary Syndrome
- Serum Zinc Levels in Women with Polycystic Ovarian Syndrome are Lower as Compared to Those without Polycystic Ovarian Syndrome: A Cohort Study
- Quercetin and polycystic ovary syndrome
- IDEA Group Consensus Statement on Medical Management of Adult Gender Incongruent Individuals Seeking Gender Affirmation as Male
- Exploring obesity-related endocrine disorders beyond diabetes: a narrative review
- Women with PCOS have a heightened risk of cardiometabolic and cardiovascular diseases: statement from the Experts Group on Inositol in Basic and Clinical Research and PCOS (EGOI-PCOS) and Italian Association of Hospital Cardiologists (ANMCO)
- A systematic review of models of care for polycystic ovary syndrome highlights the gap in the literature, especially in developing countries
- Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS
- Author response: Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Multidisciplinary screening and diagnosis of obesity related diseases: an Arabic Association for the Study of Diabetes and metabolism position statement (AASD)
- The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review
- The Role of Glucagon-Like Peptide-1 Receptor Agonists in Hair Loss: Clinical Evidence and Proposed Mechanisms
- Translating Resveratrol Research: A Systematic Review on Patents and Clinical Trials (2000–2025)
- Endocrine Management of Adult Gender-Dysphoric/Gender-Incongruent Persons: A Clinical Practice Guideline from Endocrine Society of India
- Approach to the Patient: Diagnostic Challenges in the Work Up for Polycystic Ovary Syndrome
- Insulin resistance as risk factor for the development of type 2 diabetes mellitus: a systematic approach
- Decision letter: Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- A community-oriented survey on the association between androgenetic alopecia and metabolic syndrome in Chinese people
- Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
- Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
- Dyslipidaemia in women with polycystic ovary syndrome referred to a teaching hospital in Cape Town, South Africa
- Selected abstracts from the 47th meeting of the Irish Endocrine Society Sligo, 24th & 25th November 2023
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Prevalence and Predictors of Impaired Glucose Tolerance and Diabetes Mellitus Type 2 in Patients with Polycystic Ovary Syndrome
- Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression
- The Lipid Profiles in Different Characteristics of Women with PCOS and the Interaction Between Dyslipidemia and Metabolic Disorder States: A Retrospective Study in Chinese Population